Your browser doesn't support javascript.
loading
Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysis.
Seo, Yu Ri; Lee, Junghyeon; Ryu, Han Suk; Kim, EunHee G; Kim, So Hyun; Jeong, Jieun; Jung, Hyeryeon; Jung, YeoJin; Kim, Han Byeol; Jo, Yeon Hui; Kim, Yeong Dong; Jin, Min-Sun; Lee, Yong Yook; Kim, Kristine M; Yi, Eugene C.
Afiliação
  • Seo YR; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Lee J; Department of Bio-Health Convergence, Kangwon National University, Chuncheon, Republic of Korea.
  • Ryu HS; Department of Systems Immunology, Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon, Republic of Korea.
  • Kim EG; Department of Pathology, Seoul National University Hospital, College of Medicine, Seoul National University, Seoul, Republic of Korea.
  • Kim SH; Department of Systems Immunology, Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon, Republic of Korea.
  • Jeong J; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Jung H; Department of Systems Immunology, Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon, Republic of Korea.
  • Jung Y; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Kim HB; Department of Systems Immunology, Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon, Republic of Korea.
  • Jo YH; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Kim YD; Department of Bio-Health Convergence, Kangwon National University, Chuncheon, Republic of Korea.
  • Jin MS; Department of Bio-Health Convergence, Kangwon National University, Chuncheon, Republic of Korea.
  • Lee YY; Department of Pathology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
  • Kim KM; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Yi EC; Department of Bio-Health Convergence, Kangwon National University, Chuncheon, Republic of Korea. kmkim@kwangwon.ac.kr.
Sci Rep ; 13(1): 14242, 2023 08 30.
Article em En | MEDLINE | ID: mdl-37648771
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoma / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoma / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article